article thumbnail

venBio Raises $528M for Fifth Life Sciences Fund

HIT Consultant

What You Should Know: – venBio , a leading life sciences venture capital firm, announced the successful closing of its fifth fund, venBio Fund V, with over $528M in capital commitments. – The new fund will focus on investing in biopharmaceutical companies developing innovative treatments for unmet medical needs.

article thumbnail

JPMorgan Establishes Life Sciences Private Equity Division

HIT Consultant

Morgan Asset Management announced the establishment of a new life sciences private equity team, Life Sciences Private Capital. – The Life Sciences Private Capital team will sit within J.P. . – The Life Sciences Private Capital team will sit within J.P. Anya Schiess.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Pharmaceuticals Can Unlock the Power of Influencer Marketing

Healthcare Success

But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? Listen to our latest podcast as Malcolm Bohm, strategic advisor and board member for multiple life sciences companies, reveals how influencer collaborations can transform brand advocacy and audience engagement.

article thumbnail

Classiq Launches Quantum Center for Life Sciences with NVIDIA

HIT Consultant

What You Should Know: – Classiq , NVIDIA , and Tel Aviv Sourasky Medical Center have established a new initiative, the Quantum Computing for Life Sciences & Healthcare Center, to develop and implement quantum algorithms and applications in these domains.

article thumbnail

Epic Launches Life Sciences Program with Clinical Trial Matchmaking

HIT Consultant

What You Should Know: – Epic launches Life Sciences program, expanding its work to bring together the disconnected parts of healthcare. The initial focus of the Life Sciences program includes: – Matching participating providers with clinical trial opportunities suited to the makeup of their patient populations.

article thumbnail

Healthcare & Life Science M&A Activity Plummets 1H’22

HIT Consultant

What You Should Know: – The index of Healthcare & Life Science equities tracked by Stout was down 16.8% – Healthcare & Life Science M&A activity plummeted to 338 deals in Q2 2022 versus 535 in Q2 2021 and a record 565 deals in Q4 2021. Medical Device equities were down 18.5%

article thumbnail

How the Life Sciences Industry Can Boost Diversity and Inclusion Efforts

HIT Consultant

Although it is well established that diversity improves outcomes and drives excellence, implementing diversity lags behind in many industries, including life sciences and healthcare. The pharmaceutical industry differs in many ways from other industries. Other Steps Life Sciences Companies Can Take to Improve Diversity.